Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance

Published:2023-05 Issue: Volume:161 Page:114505
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Gong Jianing,Shi Taoran,Liu Jinfeng,Pei Zerong,Liu Jingbo,Ren Xiaoliang,Li Fengyun,Qiu Feng

Funder

National Natural Science Foundation of China

Natural Science Foundation of Tianjin City

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference206 articles.

1. Natural products as multidrug resistance modulators in cancer;Kumar;Eur. J. Med. Chem.,2019

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA-Cancer J. Clin.,2021

3. Novel cytotoxic drugs: old challenges, new solutions;Ismael;Cancer Treat. Rev.,2008

4. Nanoplatform-based cascade engineering for cancer therapy;Chen;Chem. Soc. Rev.,2020

5. Engineered nanoparticles for drug delivery in cancer therapy;Sun;Angew. Chem., Int. Ed. Engl.,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. siTGF-β1 and pirfenidone contained Ionizable-Liposomal nanodrug for enhanced treatment of Idiopathic pulmonary fibrosis;Chemical Engineering Journal;2024-10

2. The Role of Intracellular and Extracellular Vesicles in the Development of Therapy Resistance in Cancer;Current Pharmaceutical Design;2024-10

3. Drug Loading in Chitosan-Based Nanoparticles;Pharmaceutics;2024-08-06

4. Role of mesoporous silica functionalized with boronic acid derivative in targeted delivery of doxorubicin and co-delivery of doxorubicin and resveratrol;Microporous and Mesoporous Materials;2024-07

5. Targeted Nano-Delivery of Flutamide with polymeric and lipid nanoparticles;European Polymer Journal;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3